RICCIO, ANNA MARIA
 Distribuzione geografica
Continente #
EU - Europa 9.680
AS - Asia 918
NA - Nord America 410
SA - Sud America 67
AF - Africa 13
OC - Oceania 1
Totale 11.089
Nazione #
IT - Italia 9.529
SG - Singapore 402
US - Stati Uniti d'America 384
CN - Cina 247
VN - Vietnam 162
FR - Francia 71
BR - Brasile 41
HK - Hong Kong 28
BD - Bangladesh 19
DE - Germania 17
FI - Finlandia 15
AR - Argentina 14
MX - Messico 13
CH - Svizzera 11
JP - Giappone 10
ID - Indonesia 9
CA - Canada 8
GB - Regno Unito 8
NL - Olanda 8
IQ - Iraq 7
TH - Thailandia 6
CO - Colombia 4
PK - Pakistan 4
TR - Turchia 4
UA - Ucraina 4
EC - Ecuador 3
EG - Egitto 3
MA - Marocco 3
UZ - Uzbekistan 3
DZ - Algeria 2
IE - Irlanda 2
IN - India 2
KE - Kenya 2
MD - Moldavia 2
MM - Myanmar 2
NP - Nepal 2
PH - Filippine 2
PL - Polonia 2
PY - Paraguay 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
ES - Italia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
SE - Svezia 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 11.089
Città #
Genova 5.689
Genoa 2.353
Rapallo 847
Vado Ligure 573
Singapore 196
San Jose 150
Lauterbourg 69
Ashburn 52
Hanoi 44
Ho Chi Minh City 43
Beijing 38
Hong Kong 27
Bordighera 21
New York 19
Council Bluffs 15
Helsinki 15
Frankfurt am Main 12
Santa Clara 12
Zurich 10
Tokyo 9
Da Nang 7
Mexico City 7
Biên Hòa 6
Haiphong 6
Orem 6
São Paulo 6
Amsterdam 5
Dallas 5
Tianjin 5
Bangkok 4
Buffalo 4
Cardiff 4
Hải Dương 4
Kyiv 4
Milan 4
Baghdad 3
Cairo 3
Guangzhou 3
Jakarta 3
Long Xuyen 3
Los Angeles 3
Recife 3
Rome 3
Atlanta 2
Bang Lamung 2
Belo Horizonte 2
Buenos Aires 2
Can Tho 2
City of London 2
Detroit 2
Dhaka 2
Dublin 2
Karbala 2
Lahore 2
Montreal 2
Nairobi 2
Naples 2
Nuremberg 2
Orlando 2
Phoenix 2
Porto Alegre 2
Querétaro 2
Quận Ba 2
Raleigh 2
Ronkonkoma 2
Shanghai 2
Tashkent 2
Thái Bình 2
Turin 2
Vancouver 2
Verona 2
Washington 2
Whittier 2
Acaraú 1
Agawam 1
Almaty Region 1
Ambato 1
Amman 1
Arima 1
Asunción 1
Bab Ezzouar 1
Barra do Piraí 1
Birmingham 1
Bogotá 1
Bonito 1
Boston 1
Braço do Norte 1
Brevard 1
Bridgeport 1
Brussels 1
Buon Ma Thuot 1
Burnsville 1
Bình Dương 1
Caloocan 1
Carapicuíba 1
Carmo do Cajuru 1
Carson 1
Cartagena 1
Casablanca 1
Catania 1
Totale 10.382
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 329
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 205
Galectin-3: An early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months 205
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. 205
Molecular phenotyping and biomarker development: Are we on our way towards targeted therapy for severe asthma? 196
In Vitro Reduction of Interleukin-8 Response to Enterococcus faecalis by Escherichia coli Strains Isolated from the Same Polymicrobial Urines 189
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 189
CD40 on adult human airway epithelial cells: expression and proinflammatory effects 182
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 179
B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease. 178
Inhibition of adhesion molecules by budesonide on a human epithelial cell line (lung carcinoma) 176
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 172
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 170
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 168
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 168
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. 168
Nasal cytology: Methodology with application to clinical practice and research 168
Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. 167
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations. 167
New insights into airway remodelling in asthma and its possible modulation. 165
Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients. 165
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 165
Assessment of extravascular lung water by quantitative ultrasound and CT in isolated bovine lung 164
Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis 163
Biomarkers and severe asthma: a critical appraisal. 162
Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients. 159
Biomarker discovery in asthma and COPD by proteomic approaches 158
Allergenius, an expert system for the interpretation of allergen microarray results 157
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 156
Antiallergic activity of topical lodoxamide on in vivo and in vitro models. 152
Molecular diagnosis and precision medicine in allergy management 152
Importance of fibroblasts-myofibroblasts in asthma-induced airway remodeling. 150
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 149
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation 149
Preliminary evidence for 'aberrant' expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy 148
Salbutamol: how does it enter smooth muscle cells? 148
A model of allergen-driven human airway contraction:beta2 pathway dysfunction without cytokine involvement. 147
Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children 147
Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects. 146
Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study. 145
Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity. 144
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 143
Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro 141
Intercellular adhesion molecule-1 on cultured human epithelial cell lines: influence of proinflammatory cytokines 136
Seasonal rhinitis and azelastine: long- or short-term treatment? 134
Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts 133
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 132
Medical treatment reverses cytokine pattern in allergic and nonallergic chronic rhinosinusitis in asthmatic children 132
On the functional consequences of bronchial basement membrane thickening 129
Local nasal immunotherapy: experimental evidences and general considerations. 128
In situ hybridization analysis of ICAM-1 (CD54) mRNA on conjunctival epithelium during allergic inflammation 127
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study 124
Intercellular adhesion molecules: Clinical Perspectives 121
Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. 121
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life 120
One year of mepolizumab. Efficacy and safety in real-life in Italy 113
IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategies 107
null 106
Duration of antiinflammatory and symptomatic effects after suspension of intranasal corticosteroid in persistent allergic rhinitis. 106
Randomised controlled trial of local heart allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis 105
Effect of statins on fibroblasts from human nasal polyps and turbinates. 105
Montelukast effects on inflammation in allergic rhinitis: a double blind placebo controlled pilot study. 103
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders 102
Different intrathyroid expression of intercellular adhesion molecule-1 (ICAM-1) in Hashimoto's thyroiditis and Graves' disease: analysis at mRNA level and association with b7.1 costimulatory molecule-Comment 101
Serum intercellular adhesion molecule-1 and long-term response to IFN-alpha2b therapy in chronic hepatitis C 101
Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients 98
CD40 and VCAM1 expression on conjunctival epithelium cells in dry eye patients 98
Small airway morphology and lung funtion in the transition from normality to chronic airway obstruction 97
Nasal endoscopy in asthmatic children: assessment of rhinosinusitis and adenoiditis incidence, correlation with cytology and microbiology 95
The relationship between clinical efficacy of specific immunotherapy and serum intercellular adhesion molecule-1 levels. 94
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 93
Preseasonal specific immunotherapy with modified Phleum pratense allergenic extracts: tolerability and effects. 91
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 85
Peripheral airways involvement in the pathogenesis of COPD. 84
VCAM-1 in conjunctival inflammation. 83
Severe asthma: One disease and multiple definitions 80
Immune induction of airway remodeling 78
Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study 68
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps 60
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy 60
Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. 57
Moderate asthma: burden, mechanisms and therapeutic perspectives 34
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 11
Totale 11.208
Categoria #
all - tutte 34.712
article - articoli 33.529
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.183
Totale 69.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 53 69
2021/2022922 19 50 93 95 30 67 56 232 51 94 26 109
2022/20231.011 99 86 9 84 157 160 28 64 169 47 93 15
2023/2024473 29 79 10 67 47 78 44 23 26 4 20 46
2024/20251.522 33 106 57 84 163 166 133 283 65 85 156 191
2025/20262.429 336 99 260 179 385 196 380 97 195 205 97 0
Totale 11.208